How Do GLP-1 Drugs Stack Up for Cardiorenal Benefits in Diabetes?

By News Health
4 hours Ago

(MedPage Today) — Three GLP-1 receptor agonists had generally comparable cardiorenal outcomes when used in type 2 diabetes, a retrospective comparative effectiveness study indicated.
Among 21,790 military veterans with diabetes, initiators of…

Source link : https://www.medpagetoday.com/endocrinology/diabetes/117917

Author :

Publish date : 2025-10-13 17:33:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Prescription Drug Coverage Options Are Shrinking for Medicare Shoppers

FDA Adds Boxed Warning for IEC-EC to CAR-T Drug

Will the Supreme Court Strike Down State Bans on 'Conversion Therapy'?

Alzheimer's Blood Test Cleared for Primary Care Use

Remimazolam: Spur on the New Benzo for Sedation or Rein It In?

Read the Memo From Trump's Doctor on His Follow-Up Medical Exam